Platelet rich plasma is widely used in orthopedics and sports medicine to support healing of musculoskeletal injuries and degenerative conditions. In the United States, PRP is commonly applied to joints, tendons, ligaments, muscles, and cartilage where blood supply is limited and natural healing is slow. By delivering concentrated growth factors directly into affected tissues, PRP aims to stimulate repair at the cellular level rather than simply reducing symptoms. Orthopedic and sports medicine specialists use PRP for both acute injuries and chronic overuse conditions, particularly when conservative treatments have failed. Its minimally invasive nature and autologous source make PRP an attractive option for patients seeking biologic approaches to musculoskeletal care.

How is platelet rich plasma used in orthopedics and sports medicine?

PRP is commonly used to treat knee osteoarthritis, hip osteoarthritis, shoulder arthritis, and ankle joint degeneration. Tendon conditions frequently treated include tennis elbow, golfer’s elbow, patellar tendinopathy, Achilles tendinopathy, and rotator cuff tendinopathy. In sports medicine settings, PRP may also be used for hamstring strains, adductor injuries, and chronic plantar fasciitis. These conditions often involve microtears, collagen breakdown, or degenerative changes that respond poorly to rest alone. PRP targets these tissues by supporting biologic repair and tendon remodeling.

For ligament injuries, PRP is injected directly into or around the damaged ligament under ultrasound or fluoroscopic guidance to improve accuracy. Growth factors released from PRP may support fibroblast activity and collagen organization during healing. In cartilage applications, PRP is commonly injected intra articularly to influence the joint environment rather than regenerate cartilage directly. U.S. orthopedic protocols often use PRP as part of a broader treatment plan that includes physical therapy and activity modification to support functional recovery.

U.S. clinical studies have reported improvements in pain scores, joint function, and activity levels following PRP treatment for certain musculoskeletal conditions. In knee osteoarthritis, multiple trials have shown moderate improvements in pain and stiffness lasting six to twelve months in selected patients. Tendinopathy studies have reported improved tendon structure and reduced symptoms over several months. Outcomes vary based on condition severity, PRP formulation, and injection technique. PRP is generally viewed as most effective in mild to moderate disease rather than advanced structural damage.

Corticosteroid injections primarily reduce inflammation and pain but do not support tissue repair. PRP, by contrast, aims to influence healing and tissue quality over time. In U.S. orthopedic practice, steroids may provide faster short term relief, while PRP is often associated with longer lasting improvements. Steroids may also carry risks with repeated use, including cartilage damage and tendon weakening. PRP is sometimes chosen when patients seek alternatives that avoid these potential effects and focus on biologic repair.

Find out if platelet rich plasma may help with orthopedic or sports related injuries

This information is educational and not a substitute for professional advice. Platelet rich plasma is not FDA approved for all uses. Patients should consult a licensed U.S. clinician before pursuing treatment.